Clin2
NCT07839715Possibly a fitNot yet recruiting

Pain relief after DIEP flap breast reconstruction

Post-operative PainDIEP Flap Breast ReconstructionDIEP FlapOpioidSuzetrigineERAS

Part of Pain clinical trials.

This study tests a new pain medication called suzetrigine after DIEP flap breast reconstruction surgery. The goal is to see if it can control pain with fewer side effects than standard opioids, which may help you recover more comfortably.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
198 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years old or older.
  • You are scheduled for DIEP flap breast reconstruction surgery (one or both breasts).
  • You speak English.
  • You have not been using opioids for pain for more than 30 days in the last 90 days.
  • You do not have a history of substance use disorder, chronic pain requiring daily pain medication, or active infection requiring antibiotics.
  • You are not pregnant and are not a prisoner.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07539623Recruiting· Phase 3
Pain relief with suzetrigine after heart or weight-loss surgery

This study tests whether suzetrigine, a new pain medication, can reduce the need for opioids (strong painkillers) after cardiac or bariatric surgery. The goal is to help patients manage pain with fewer opioid-related side effects.

New York, New York
NCT07821931Not yet recruiting· Phase 4
Pain relief after tonsillectomy with suzetrigine

This study tests a new pain medicine, suzetrigine, to see if it can reduce the need for opioids after a tonsillectomy or similar throat surgery. It aims to provide effective pain control with fewer opioid-related risks.

Palo Alto, California
NCT07548385Recruiting· Phase 3
New pain medicine for after knee replacement surgery

This study tests a new medication called suzetrigine to help manage pain after knee replacement surgery. The goal is to see if it reduces pain and discomfort better than current treatments.

New York, New York
NCT07226700Recruiting· Phase 3
Suzetrigine for pain after hip replacement surgery

This study tests an investigational pain medicine called suzetrigine to see how well it controls pain after total hip replacement surgery. It is for adults 18–80 who are having a first-time hip replacement and can receive spinal anesthesia.

New York, New York
NCT07463430Enrolling by invitation· Phase 4
Suzetrigine for pain after non-mastectomy breast surgery

This trial tests a new pain medication, suzetrigine, for people having breast surgery (not mastectomy) who are expected to have moderate pain. It checks if this drug works well compared to standard options.

San Diego, California
NCT07672015Recruiting· Phase 4
Testing a new pain drug in surgery patients at risk for opioid dependence

This trial tests a new painkiller called suzetrigine for post-surgery pain. It's designed for people whose medical records suggest they may have a higher chance of needing strong painkillers (opioids) long after surgery. We want to see if suzetrigine works better at preventing that.

La Jolla, California

Hear when a new Post Operative Pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.